Wearables such as smartwatches are already an integral part of our everyday lives. They track our pulse, the number of steps we take and our sleep rhythm. Glucose measurement using CGM systems is currently considered the gold standard. Can Dincer, Professor of Sensors and Wearables for Healthcare at the Technical University of Munich (TUM), explains in an interview in which direction the development can still go in the future.
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities
Exacerbation frequency is associated with cardiopulmonary disease burden
- Multiple myeloma
DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14
- Catheter ablation for atrial fibrillation 2025
Pulsed field versus radio frequency – where do we stand?
- Atopic dermatitis
From skin barrier disorder to atopic march?
- From the late residual valve to independent therapy